al. identified inherited compound heterozygous variants of FBN2 in embryonic loss, our SV analysis in stillbirth in Family 4 (see S1 File) confirmed a de novo SV (chr5:128335405) impacting FBN2, suggesting variants disrupting the FBN2 gene may be incompatible with development to the fetal stage. The gene discussed is FBN2; the disease is Stillbirth.